The latest research indicates that Ctbp2, as a key metabolite receptor, plays a crucial role in the pathogenesis of metabolic imbalance and obesity, suggesting the potential of targeting Ctbp2 for the treatment of metabolic diseases (Sekiya et al. 2021; Sekiya et al. 2024). This evidence concerns the gene CTBP2 and Other metabolic disease.